CLEVELAND (MedPage Today) — The U.S. will buy 13 million additional courses of antiviral medications to replenish the strategic national stockpile and will send 400,000 doses to Mexico for treatment of 2009 H1N1 (swine) flu cases there, CDC officials said today.
No Comments »
Filed under: General Health News
TORONTO (MedPage Today) — Although 97 cases of 2009 H1N1 (swine) flu have been confirmed in Mexico, complete information is available on only a handful, the CDC said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA gave the official thumbs-up for the first antihypertensive polypill, Exforge HCT (amlodipine, valsartan, and hydrochlorothiazide).
No Comments »
Filed under: Pharmacy News
SAN FRANCISCO (MedPage Today) — The FDA has approved the Creon brand of delayed-release pancrelipase for treatment of exocrine pancreatic insufficiency.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — Hydroxycut supplements, a line of diet products that sold more than 9 million units last year, have been linked to severe liver damage, including the death of a 19-year-old man and at least one liver transplant, the FDA said today.
No Comments »
Filed under: Pharmacy News
Sirion Therapeutics, Inc. announced that eight presentations related to the Company’s products, pipeline and research will be presented at the 2009 annual meeting of The Association for Research in Vision and Ophthalmology (ARVO) in Ft. Lauderdale, FL. These presentations include data related to Durezol(TM) (difluprednate ophthalmic emulsion) [...]
No Comments »
Filed under: Pharmacy News
“Controlling Conflict of Interest — Proposals From the Institute of Medicine,” New England Journal of Medicine: In the perspective, NEJM correspondent Robert Steinbrook discusses Institute of Medicine
No Comments »
Filed under: Pharmacy News
The US Food and Drug Administration (FDA) has approved Exforge HCT (amlodipine, valsartan, hydrochlorothiazide), the only blood pressure (BP) treatment to combine three medications in a single pill. Exforge HCT combines the number one prescribed calcium channel blocker, angiotensin receptor blocker, and diuretic in one pill, and is an important new option for patients who [...]
No Comments »
Filed under: Pharmacy News
An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received orphan drug designation in the US. Axentis Pharma of Zurich, Switzerland announced that this sought-after designation has been granted to its product candidate Fluidosomes-tobramycin, a therapeutic that will soon be tested in Phase II clinical trials. The company has now [...]
No Comments »
Filed under: Pharmacy News
Tigris Pharmaceuticals, Inc., a privately held drug development company, announced that preclinical data were presented on its novel molecule, AFP-464, during the recent AACR 100th Annual Meeting 2009 in Denver. “This research represents a significant advancement in the treatment of Triple Negative Breast Cancer, one of the most aggressive forms of invasive breast cancer,” stated [...]
No Comments »
Filed under: Pharmacy News
